table of content
1 Study Coverage
1.1 RNA Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global RNA Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 Market by Application
1.3.1 Global RNA Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global RNA Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global RNA Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global RNA Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global RNA Vaccines Sales by Region
2.4.1 Global RNA Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales RNA Vaccines by Region (2023-2028)
2.5 Global RNA Vaccines Revenue by Region
2.5.1 Global RNA Vaccines Revenue by Region (2017-2022)
2.5.2 Global RNA Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global RNA Vaccines Sales by Manufacturers
3.1.1 Global Top RNA Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global RNA Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of RNA Vaccines in 2021
3.2 Global RNA Vaccines Revenue by Manufacturers
3.2.1 Global RNA Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global RNA Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by RNA Vaccines Revenue in 2021
3.3 Global RNA Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global RNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global RNA Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global RNA Vaccines Sales by Type
4.1.1 Global RNA Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global RNA Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global RNA Vaccines Sales Market Share by Type (2017-2028)
4.2 Global RNA Vaccines Revenue by Type
4.2.1 Global RNA Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global RNA Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global RNA Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global RNA Vaccines Price by Type
4.3.1 Global RNA Vaccines Price by Type (2017-2022)
4.3.2 Global RNA Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global RNA Vaccines Sales by Application
5.1.1 Global RNA Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global RNA Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global RNA Vaccines Sales Market Share by Application (2017-2028)
5.2 Global RNA Vaccines Revenue by Application
5.2.1 Global RNA Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global RNA Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global RNA Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global RNA Vaccines Price by Application
5.3.1 Global RNA Vaccines Price by Application (2017-2022)
5.3.2 Global RNA Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America RNA Vaccines Market Size by Type
6.1.1 North America RNA Vaccines Sales by Type (2017-2028)
6.1.2 North America RNA Vaccines Revenue by Type (2017-2028)
6.2 North America RNA Vaccines Market Size by Application
6.2.1 North America RNA Vaccines Sales by Application (2017-2028)
6.2.2 North America RNA Vaccines Revenue by Application (2017-2028)
6.3 North America RNA Vaccines Market Size by Country
6.3.1 North America RNA Vaccines Sales by Country (2017-2028)
6.3.2 North America RNA Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe RNA Vaccines Market Size by Type
7.1.1 Europe RNA Vaccines Sales by Type (2017-2028)
7.1.2 Europe RNA Vaccines Revenue by Type (2017-2028)
7.2 Europe RNA Vaccines Market Size by Application
7.2.1 Europe RNA Vaccines Sales by Application (2017-2028)
7.2.2 Europe RNA Vaccines Revenue by Application (2017-2028)
7.3 Europe RNA Vaccines Market Size by Country
7.3.1 Europe RNA Vaccines Sales by Country (2017-2028)
7.3.2 Europe RNA Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific RNA Vaccines Market Size by Type
8.1.1 Asia Pacific RNA Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific RNA Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific RNA Vaccines Market Size by Application
8.2.1 Asia Pacific RNA Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific RNA Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific RNA Vaccines Market Size by Region
8.3.1 Asia Pacific RNA Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific RNA Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America RNA Vaccines Market Size by Type
9.1.1 Latin America RNA Vaccines Sales by Type (2017-2028)
9.1.2 Latin America RNA Vaccines Revenue by Type (2017-2028)
9.2 Latin America RNA Vaccines Market Size by Application
9.2.1 Latin America RNA Vaccines Sales by Application (2017-2028)
9.2.2 Latin America RNA Vaccines Revenue by Application (2017-2028)
9.3 Latin America RNA Vaccines Market Size by Country
9.3.1 Latin America RNA Vaccines Sales by Country (2017-2028)
9.3.2 Latin America RNA Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa RNA Vaccines Market Size by Type
10.1.1 Middle East and Africa RNA Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa RNA Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa RNA Vaccines Market Size by Application
10.2.1 Middle East and Africa RNA Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa RNA Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa RNA Vaccines Market Size by Country
10.3.1 Middle East and Africa RNA Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa RNA Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Corporation Information
11.1.2 Moderna Therapeutics Overview
11.1.3 Moderna Therapeutics RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Moderna Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Moderna Therapeutics Recent Developments
11.2 CureVac
11.2.1 CureVac Corporation Information
11.2.2 CureVac Overview
11.2.3 CureVac RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CureVac RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CureVac Recent Developments
11.3 Translate Bio
11.3.1 Translate Bio Corporation Information
11.3.2 Translate Bio Overview
11.3.3 Translate Bio RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Translate Bio RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Translate Bio Recent Developments
11.4 BioNTech
11.4.1 BioNTech Corporation Information
11.4.2 BioNTech Overview
11.4.3 BioNTech RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 BioNTech RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BioNTech Recent Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Corporation Information
11.5.2 Sangamo Therapeutics Overview
11.5.3 Sangamo Therapeutics RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sangamo Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sangamo Therapeutics Recent Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Corporation Information
11.6.2 Argos Therapeutics Overview
11.6.3 Argos Therapeutics RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Argos Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Argos Therapeutics Recent Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Corporation Information
11.7.2 In-Cell-Art Overview
11.7.3 In-Cell-Art RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 In-Cell-Art RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 In-Cell-Art Recent Developments
11.8 eTheRNA
11.8.1 eTheRNA Corporation Information
11.8.2 eTheRNA Overview
11.8.3 eTheRNA RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 eTheRNA RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 eTheRNA Recent Developments
11.9 Ethris
11.9.1 Ethris Corporation Information
11.9.2 Ethris Overview
11.9.3 Ethris RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ethris RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ethris Recent Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Corporation Information
11.10.2 Tiba Biotechnology Overview
11.10.3 Tiba Biotechnology RNA Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Tiba Biotechnology RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Tiba Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 RNA Vaccines Industry Chain Analysis
12.2 RNA Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 RNA Vaccines Production Mode & Process
12.4 RNA Vaccines Sales and Marketing
12.4.1 RNA Vaccines Sales Channels
12.4.2 RNA Vaccines Distributors
12.5 RNA Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 RNA Vaccines Industry Trends
13.2 RNA Vaccines Market Drivers
13.3 RNA Vaccines Market Challenges
13.4 RNA Vaccines Market Restraints
14 Key Findings in The Global RNA Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
